USPTO serial 76211321
AVANTAVA
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- DALIER, JOHN DAVID
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AVANTAVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATIONS, FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CENTRAL NERVOUS SYSTEM DISEASES, CANCER, INFLAMMATION AND INFLAMMATORY DISEASES, RESPIRATORY AND INFECTIOUS DISEASES AND FOR DIAGNOSTIC IMAGING | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 1, 2002 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Sep 17, 2001 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 21, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 1, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 18, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 13, 2001 | DOCK | ASSIGNED TO EXAMINER | — |